PB 46 of 2013
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 3)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated            26  July   2013
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 3).
         (2)   This Determination may also be cited as PB 46 of 2013.
2              Commencement
                This Determination commences on 1 August 2013.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
[1]     Schedule 1, after item dealing with Abciximab
 
Insert
 
Abiraterone
 
[2]     Schedule 1, after item dealing with Balsalazide
 
Omit
 
BCG Immunotherapeutic (Bacillus Calmette-Guerin/Connaught strain)
BCG-TICE (Bacillus Calmette-Guerin/Tice strain)
 
Insert
 
Bacillus Calmette and Guerin Connaught strain
Bacillus Calmette and Guerin, Tice strain
 
[3]     Schedule 1, after item dealing with Glycerol
 
Insert
 
Glycomacropeptide and essential amino acids
Glycomacropeptide and essential amino acids with vitamins and minerals
 
 
[4]     Schedule 1, after item dealing with Interferon gamma-1b
 
Insert
 
Ipilimumab
 
[5]     Schedule 1, after item dealing with Miconazole
 
Insert
 
Mifepristone
 
[6]     Schedule 1, after item dealing with Minoxidil
 
Omit
 
Misoprostol
 
[7]     Schedule 1, after item dealing with Modafinil
 
Omit
 
Montelukast
 
[8]     Schedule 2, after item dealing with Candesartan
 
Insert
 
Candesartan with Hydrochlorothiazide
 
[9]     Schedule 2, after item dealing with Lamivudine
 
Insert
 
Lamivudine with Zidovudine
 
[10]   Schedule 2, after item dealing with Mirtazapine
 
Insert
 
Misoprostol
 
[11]   Schedule 2, after item dealing with Mometasone
 
Insert
 
Montelukast
 
[12]   Schedule 2, after item dealing with Telmisartan
 
Insert
 
Telmisartan with Hydrochlorothiazide